Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015, Article ID 430741, 7 pages
http://dx.doi.org/10.1155/2015/430741
Research Article

Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes

1University Eye Clinic Maastricht, Postbus 5800, 6202 AZ Maastricht, Netherlands
2Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University, Maastricht, Netherlands
3Sektion Pädiatrische Endokrinologie u. Diabetologie, Universität Ulm, Germany

Received 31 May 2015; Revised 20 August 2015; Accepted 27 August 2015

Academic Editor: Shun-Fa Yang

Copyright © 2015 Yuan Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Klein, T. Peto, A. Bird, and M. R. Vannewkirk, “The epidemiology of age-related macular degeneration,” American Journal of Ophthalmology, vol. 137, no. 3, pp. 486–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. S. Friedman, B. J. O'Colmain, B. Muñoz et al., “Prevalence of age-related macular degeneration in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 564–572, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Bamashmus, B. Matlhaga, and G. N. Dutton, “Causes of blindness and visual impairment in the West of Scotland,” Eye, vol. 18, no. 3, pp. 257–261, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. D. Jager, W. F. Mieler, and J. W. Miller, “Age-related macular degeneration,” The New England Journal of Medicine, vol. 358, no. 24, pp. 2544–2617, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. S. Lim, P. Mitchell, J. M. Seddon, F. G. Holz, and T. Y. Wong, “Age-related macular degeneration,” The Lancet, vol. 379, no. 9827, pp. 1728–1738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Smith, J. Assink, R. Klein et al., “Risk factors for age-related macular degeneration: pooled findings from three continents,” Ophthalmology, vol. 108, no. 4, pp. 697–704, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Seddon, J. Cote, N. Davis, and B. Rosner, “Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio,” Archives of Ophthalmology, vol. 121, no. 6, pp. 785–792, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Seddon, J. Cote, and B. Rosner, “Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake,” Archives of Ophthalmology, vol. 121, no. 12, pp. 1728–1737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. E. Myers, B. E. Klein, R. Gangnon, T. A. Sivakumaran, S. K. Iyengar, and R. Klein, “Cigarette smoking and the natural history of age-related macular degeneration: the beaver dam eye study,” Ophthalmology, vol. 121, no. 10, pp. 1949–1955, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Mozaffarieh, S. Sacu, and A. Wedrich, “The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence,” Nutrition Journal, vol. 2, article 20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Delcourt, I. Carrière, M. Delage et al., “Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA study,” Investigative Ophthalmology & Visual Science, vol. 47, no. 6, pp. 2329–2335, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Y. Chew, J. P. SanGiovanni, F. L. Ferris et al., “Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4,” JAMA Ophthalmology, vol. 131, no. 7, pp. 843–850, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. E. Aronow and E. Y. Chew, “Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions,” Current Opinion in Ophthalmology, vol. 25, no. 3, pp. 186–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Mares-Perlman, A. I. Fisher, R. Klein et al., “Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey,” American Journal of Epidemiology, vol. 153, no. 5, pp. 424–432, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. van Leeuwen, S. Boekhoorn, J. R. Vingerling et al., “Dietary intake of antioxidants and risk of age-related macular degeneration,” Journal of the American Medical Association, vol. 294, no. 24, pp. 3101–3107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Hesterberg, S. Schanzer, A. Patzelt et al., “Raman spectroscopic analysis of the carotenoid concentration in egg yolks depending on the feeding and housing conditions of the laying hens,” Journal of Biophotonics, vol. 5, no. 1, pp. 33–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Seddon, U. A. Ajani, R. D. Sperduto et al., “Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye disease case-control study group,” The Journal of the American Medical Association, vol. 272, no. 18, pp. 1413–1420, 1994. View at Google Scholar · View at Scopus
  18. N. P. Davies and A. B. Morland, “Macular pigments: their characteristics and putative role,” Progress in Retinal and Eye Research, vol. 23, no. 5, pp. 533–559, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Bone, J. T. Landrum, L. Fernandez, and S. L. Tarsis, “Analysis of the macular pigment by HPLC: retinal distribution and age study,” Investigative Ophthalmology and Visual Science, vol. 29, no. 6, pp. 843–849, 1988. View at Google Scholar · View at Scopus
  20. P. DeMarco, J. Pokorny, and V. C. Smith, “Full-spectrum cone sensitivity functions for X-chromosome-linked anomalous trichromats,” Journal of the Optical Society of America A, vol. 9, no. 9, pp. 1465–1476, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. R. A. Bone, J. T. Landrum, and A. Cains, “Optical density spectra of the macular pigment in vivo and in vitro,” Vision Research, vol. 32, no. 1, pp. 105–110, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. L. T. Sharpe, A. Stockman, H. Knau, and H. Jägle, “Macular pigment densities derived from central and peripheral spectral sensitivity differences,” Vision Research, vol. 38, no. 21, pp. 3233–3239, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. J. T. Landrum, R. A. Bone, and M. D. Kilburn, “The macular pigment: a possible role in protection from age-related macular degeneration,” Advances in Pharmacology, vol. 38, pp. 537–556, 1997. View at Google Scholar · View at Scopus
  24. F. Khachik, P. S. Bernstein, and D. L. Garland, “Identification of lutein and zeaxanthin oxidation products in human and monkey retinas,” Investigative Ophthalmology and Visual Science, vol. 38, no. 9, pp. 1802–1811, 1997. View at Google Scholar · View at Scopus
  25. A. Kijlstra, Y. Tian, E. R. Kelly, and T. T. J. M. Berendschot, “Lutein: more than just a filter for blue light,” Progress in Retinal and Eye Research, vol. 31, no. 4, pp. 303–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. X.-H. Jin, K. Ohgami, K. Shiratori et al., “Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats,” Investigative Ophthalmology and Visual Science, vol. 47, no. 6, pp. 2562–2568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S.-Y. Li, Z.-J. Fu, H. Ma et al., “Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion,” Investigative Ophthalmology and Visual Science, vol. 50, no. 2, pp. 836–843, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-Y. Li and A. C. Y. Lo, “Lutein protects RGC-5 cells against hypoxia and oxidative stress,” International Journal of Molecular Sciences, vol. 11, no. 5, pp. 2109–2117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Muriach, F. Bosch-Morell, G. Alexander et al., “Lutein effect on retina and hippocampus of diabetic mice,” Free Radical Biology and Medicine, vol. 41, no. 6, pp. 979–984, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Sasaki, Y. Ozawa, T. Kurihara et al., “Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes,” Diabetologia, vol. 53, no. 5, pp. 971–979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Brazionis, K. Rowley, C. Itsiopoulos, and K. O'Dea, “Plasma carotenoids and diabetic retinopathy,” British Journal of Nutrition, vol. 101, no. 2, pp. 270–277, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Khandhadia, V. Cipriani, J. R. W. Yates, and A. J. Lotery, “Age-related macular degeneration and the complement system,” Immunobiology, vol. 217, no. 2, pp. 127–146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Nozaki, B. J. Raisler, E. Sakurai et al., “Drusen complement components C3a and C5a promote choroidal neovascularization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2328–2333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. O. Edwards, R. Ritter III, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer, “Complement factor H polymorphism and age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 421–424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. R. J. Klein, C. Zeiss, E. Y. Chew et al., “Complement factor H polymorphism in age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 385–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. L. A. Hecker, A. O. Edwards, E. Ryu et al., “Genetic control of the alternative pathway of complement in humans and age-related macular degeneration,” Human Molecular Genetics, vol. 19, no. 1, pp. 209–215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. H. P. N. Scholl, P. C. Issa, M. Walier et al., “Systemic complement activation in age-related macular degeneration,” PLoS ONE, vol. 3, no. 7, Article ID e2593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Reynolds, M. E. Hartnett, J. P. Atkinson, P. C. Giclas, B. Rosner, and J. M. Seddon, “Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes,” Investigative Ophthalmology and Visual Science, vol. 50, no. 12, pp. 5818–5827, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. S. Silva, A. G. Teixeira, L. Bavia et al., “Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of complement factor H Tyr402His polymorphism,” Molecular Vision, vol. 18, pp. 2288–2299, 2012. View at Google Scholar · View at Scopus
  40. A. Kijlstra, E. C. La Heij, and F. Hendrikse, “Immunological factors in the pathogenesis and treatment of age-related macular degeneration,” Ocular Immunology and Inflammation, vol. 13, no. 1, pp. 3–11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Izumi-Nagai, N. Nagai, K. Ohgami et al., “Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2555–2562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Tian, A. Kijlstra, R. L. P. van der Veen, M. Makridaki, I. J. Murray, and T. T. J. M. Berendschot, “The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d,” PLoS ONE, vol. 8, no. 8, Article ID e73387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Tian, A. Kijlstra, R. L. P. van der Veen, M. Makridaki, I. J. Murray, and T. T. J. M. Berendschot, “Lutein supplementation leads to decreased soluble complement membrane attack complex sC5b-9 plasma levels,” Acta Ophthalmologica, vol. 93, no. 2, pp. 141–145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. P. H. Lesavre and H. J. Muller-Eberhard, “Mechanism of action of factor D of the alternative complement pathway,” The Journal of Experimental Medicine, vol. 148, no. 6, pp. 1498–1509, 1978. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Jing, Y. S. Babu, D. Moore et al., “Structures of native and complexed complement factor D: Implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity,” Journal of Molecular Biology, vol. 282, no. 5, pp. 1061–1081, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. R. T. White, D. Damm, N. Hancock et al., “Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue,” The Journal of Biological Chemistry, vol. 267, no. 13, pp. 9210–9213, 1992. View at Google Scholar · View at Scopus
  47. H.-Y. Chung, A. L. A. Ferreira, S. Epstein, S. A. R. Paiva, C. Castaneda-Sceppa, and E. J. Johnson, “Site-specific concentrations of carotenoids in adipose tissue: relations with dietary and serum carotenoid concentrations in healthy adults,” The American Journal of Clinical Nutrition, vol. 90, no. 3, pp. 533–539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. A. Olson, “Serum levels of vitamin A and carotenoids as reflectors of nutritional status,” Journal of the National Cancer Institute, vol. 73, no. 6, pp. 1439–1444, 1984. View at Google Scholar · View at Scopus
  49. R. S. Parker, “Carotenoids in human blood and tissues,” Journal of Nutrition, vol. 119, no. 1, pp. 101–104, 1989. View at Google Scholar · View at Scopus
  50. M. Wabitsch, R. E. Brenner, I. Melzner et al., “Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation,” International Journal of Obesity and Related Metabolic Disorders, vol. 25, no. 1, pp. 8–15, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Fischer-Posovszky, F. S. Newell, M. Wabitsch, and H. E. Tornqvist, “Human SGBS cells—a unique tool for studies of human fat cell biology,” Obesity Facts, vol. 1, no. 4, pp. 184–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Rosenow, T. N. Arrey, F. G. Bouwman et al., “Identification of novel human adipocyte secreted proteins by using SGBS cells,” Journal of Proteome Research, vol. 9, no. 10, pp. 5389–5401, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. H.-Y. Chung, H. M. Rasmussen, and E. J. Johnson, “Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men,” Journal of Nutrition, vol. 134, no. 8, pp. 1887–1893, 2004. View at Google Scholar · View at Scopus
  55. M. M. Calvo, “Lutein: a valuable ingredient of fruit and vegetables,” Critical Reviews in Food Science and Nutrition, vol. 45, no. 7-8, pp. 671–696, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. H. C. Furr and R. M. Clark, “Intestinal absorption and tissue distribution of carotenoids,” Journal of Nutritional Biochemistry, vol. 8, no. 7, pp. 364–377, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. B. A. Clevidence and J. G. Bieri, “Association of carotenoids with human plasma lipoproteins,” Methods in Enzymology, vol. 214, pp. 33–46, 1993. View at Publisher · View at Google Scholar · View at Scopus
  58. E. R. Bovier, R. D. Lewis, and B. R. Hammond Jr., “The relationship between lutein and zeaxanthin status and body fat,” Nutrients, vol. 5, no. 3, pp. 750–757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. E. J. Johnson, B. R. Hammond, K.-J. Yeum et al., “Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density,” The American Journal of Clinical Nutrition, vol. 71, no. 6, pp. 1555–1562, 2000. View at Google Scholar · View at Scopus
  60. Y. Tian, A. Kijlstra, C. A. B. Webers, and T. T. J. M. Berendschot, “Lutein and Factor D: two intriguing players in the field of age-related macular degeneration,” Archives of Biochemistry and Biophysics, vol. 572, pp. 49–53, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Maslowska, H. W. Wang, and K. Cianflone, “Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence,” Vitamins and Hormones, vol. 70, pp. 309–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. W. D. Campbell, E. Lazoura, N. Okada, and H. Okada, “Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N,” Microbiology and Immunology, vol. 46, no. 2, pp. 131–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Cianflone and M. Maslowska, “Differentiation-induced production of ASP in human adipocytes,” European Journal of Clinical Investigation, vol. 25, no. 11, pp. 817–825, 1995. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Antras, F. Lasnier, and J. Pairault, “Adipsin gene expression in 3T3-F442A adipocytes is posttranscriptionally down-regulated by retinoic acid,” The Journal of Biological Chemistry, vol. 266, no. 2, pp. 1157–1161, 1991. View at Google Scholar · View at Scopus
  65. N. S. Bora, S. Kaliappan, P. Jha et al., “Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H,” The Journal of Immunology, vol. 177, no. 3, pp. 1872–1878, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. M. G. Erke, G. Bertelsen, T. Peto, A. K. Sjølie, H. Lindekleiv, and I. Njølstad, “Cardiovascular risk factors associated with age-related macular degeneration: the Tromsø study,” Acta Ophthalmologica, vol. 92, no. 7, pp. 662–669, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Hertle, C. D. A. Stehouwer, and M. M. J. van Greevenbroek, “The complement system in human cardiometabolic disease,” Molecular Immunology, vol. 61, no. 2, pp. 135–148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. B. Rohrer, Y. Guo, K. Kunchithapautham, and G. S. Gilkeson, “Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage,” Investigative Ophthalmology & Visual Science, vol. 48, no. 11, pp. 5282–5289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. K. J. Katschke Jr., P. Wu, R. Ganesan et al., “Inhibiting alternative pathway complement activation by targeting the factor D exosite,” The Journal of Biological Chemistry, vol. 287, no. 16, pp. 12886–12892, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. D. V. Do, D. J. Pieramici, M. van Lookeren Campagne et al., “A phase ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophy,” Retina, vol. 34, no. 2, pp. 313–320, 2014. View at Publisher · View at Google Scholar · View at Scopus